Growth Factors and Anticatabolic Substances for Prevention and Management of Intervertebral Disc Degeneration

Intervertebral disc (IVD) degeneration is frequent, appearing from the second decade of life and progressing with age. Conservative management often fails, and patients with IVD degeneration may need surgical intervention. Several treatment strategies have been proposed, although only surgical disce...

Full description

Saved in:
Bibliographic Details
Main Authors: Umile Giuseppe Longo (Author), Stefano Petrillo (Author), Edoardo Franceschetti (Author), Nicola Maffulli (Author), Vincenzo Denaro (Author)
Format: Book
Published: Hindawi Limited, 2012-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_523c3eb0db8c49bfb21b4ea7707029b2
042 |a dc 
100 1 0 |a Umile Giuseppe Longo  |e author 
700 1 0 |a Stefano Petrillo  |e author 
700 1 0 |a Edoardo Franceschetti  |e author 
700 1 0 |a Nicola Maffulli  |e author 
700 1 0 |a Vincenzo Denaro  |e author 
245 0 0 |a Growth Factors and Anticatabolic Substances for Prevention and Management of Intervertebral Disc Degeneration 
260 |b Hindawi Limited,   |c 2012-01-01T00:00:00Z. 
500 |a 1687-966X 
500 |a 1687-9678 
500 |a 10.1155/2012/897183 
520 |a Intervertebral disc (IVD) degeneration is frequent, appearing from the second decade of life and progressing with age. Conservative management often fails, and patients with IVD degeneration may need surgical intervention. Several treatment strategies have been proposed, although only surgical discectomy and arthrodesis have been proved to be predictably effective. Biological strategies aim to prevent and manage IVD degeneration, improving the function and anabolic and reparative capabilities of the nucleus pulposus and annulus fibrosus cells and inhibiting matrix degradation. At present, clinical applications are still in their infancy. Further studies are required to clarify the role of growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration. 
546 |a EN 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Stem Cells International, Vol 2012 (2012) 
787 0 |n http://dx.doi.org/10.1155/2012/897183 
787 0 |n https://doaj.org/toc/1687-966X 
787 0 |n https://doaj.org/toc/1687-9678 
856 4 1 |u https://doaj.org/article/523c3eb0db8c49bfb21b4ea7707029b2  |z Connect to this object online.